ENDOTHELIAL DYSFUNCTION AS A RISK FACTOR OF ARTERIAL HYPERTENSION PROGRESSION

Endothelial condition is one of the main factors determining the function of the healthy vessels and its change in arterial hypertension (AH). The aim of this study is to evaluate the role of endothelial dysfunction in prognosis of AH. Material and Methods. 918 young adults aged 20–29 years old and normal level of blood pressure (BP) were enrolled in a prospective observational study. The endothelial function was assessed using a brachial reactive hyperemia test with calculation of peak systolic (Vps), maximal terminal diastolic (Ved), time average maximal (TAMX), time average (TAV) blood flow velocity, spectral broadening index (SBI), resistance index (RI), pulsation index (PI), systole-diastolic ratio (SD), intima–media thickness and brachial flow mediated dilation (FMD). Further, the observation period lasted for 5 years. Two groups were chosen according to the level of BP: the 1st group included the patients with AH (BP level 140/90 mm Hg and higher), the 2nd group consisted of the patients with the normal level of BP (lower 140/90 mm Hg). Results. 78 persons were withdrawn from the study for different reasons during observation period. AH was found in 144 participants (18.8%, 95% CI 16.2-21.7%) — group 1, 620 people of group 2 showed normal BP in 620 (81.2%; 95% confidence Interval (CI) 78.3–83.8%). In group 1 FMD was 7.5 (5.3; 9.9)%, in group 2 — 12.3 (10.2; 13.4)% (p<0,05). Based on the data of univariate analysis of male sex (odds ratio (OR) 10.8; 95% CI 7.63–15.28), body mass index (BMI) > 25 kg/m2 (OR 7.17; 95% CI 5.65–9.10), smoking (OR 5.61; 95% CI 4.5–6.98), high normal BP (OR 10.68; 95% CI 6.92– 14.51) and FMD <10% (OR 3.49; 95% CI 2.19–5.57) were significant risk factors of AH. The results of multivariate analysis BMI > 25 kg/m2 , high normal BP and FMD < 10% were independent risk factors. Conclusion. Endothelial dysfunction is an independent risk factor of AH in young patients with initially normal level of AD during 5 years.

1. Иванова О.В., Балахонова Т.В., Соболева Г.Н. и др. Состояние эндотелийзависимой вазодилатации плечевой артерии у больных гипертонической болезнью, оцениваемое с помощью ультразвука высокого разрешения / Кардиология. 1997; 7: 41–46 [Ivanova O.V., Balahonova T.V., Soboleva G.N. et al. Endothelium-dependent vasodilation of the brachial artery in patients with essential hypertension, assessed with high resolution ultrasound / Kardiologiia. 1997; 7: 41–46] (In Russ).

2. Лямина С.В., Ребров А.П., Лямина Н.П., Сенчихин В.Н. Диагностически значимые маркеры эндотелиальной дисфункции у больных молодого возраста с артериальной гипертонией / Регионарное кровообращение и микроциркуляция. 2007; 6(3): 59–65. https://elibrary.ru/download/ elibrary_13023553_67958047.pdf. [Liamina S.V., Rebrov A.P., Liamina N.P., Senchihin V.N. Diagnostically significant markers of endothelial dysfunction in young patients with arterial hypertension / Regional circulation and microcirculation. 2007; 6(3): 59–65] (In Russ).

3. Corretti M.C., Anderson T.J., Benjamin E.J. et al. Guidelines for the ultrasound assessment of endothelial-dependent flowmediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force / J. Am. Coll. Cardiol. 2002; 39(2): 257–265. http://www.sciencedirect.com/science/ article/pii/S0735109701017466?via%3Dihub.

4. Felmeden D.C., Spencer C.G., Blann A.D. et al. Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment / Hypertension. 2003; 41(3): 528–533. http://hyper.ahajournals. org/content/41/3/528.long.

5. Gray L., Lee I.M., Sesso H.D., Batty G.D. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study) / J. Am. Coll. Cardiol. 2011; 58(23): 2396–2403. http://www.sciencedirect. com/science/article/pii/S0735109711031433?via%3Dihub.

6. Hlubocká Z., Umnerová V., Heller S. et al. Is mild essential hypertension without obvious organ complications and risk factors associated with increased levels of circulating markers of endothelial dysfunction? Effect of ACE inhibitor therapy / Vnitr. Lek. 2002; 48(8): 718–723.

7. Kassan M., Galán M., Partyka M. et al. Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice / Arterioscler. Thromb. Vasc. Biol. 2012; 32(7): 1652–1661. http://atvb.ahajournals.org/ content/32/7/1652.long.

8. Liu G., Zhang S.L., Liu P.M. et al. Biomarkers of endothelial dysfunction and risk of early organ damage: a comparison between patients with primary aldosteronism and essential hypertension / Zhonghua Xin Xue Guan Bing Za Zhi. 2012; 40(8): 640–644.

9. Lobato N.S., Filgueira F.P., Akamine E.H. et al. Mechanisms of endothelial dysfunction in obesity-associated hypertension / Braz. J. Med. Biol. Res. 2012; 45(5): 392–400. http://www.scielo.br/ scielo.php?script=sci_arttext&pid=S0100-879X201200750005 8&lng=en&nrm=iso&tlng=en.

10. Neves M.F., Kasal D.A., Cunha A.R., Medeiros F. Vascular dysfunction as target organ damage in animal models of hypertension / Int. J. Hypertens. 2012; 2012: 187526. https://www.hindawi. com/journals/ijhy/2012/187526/.

11. Neunteufl T., Heher S., Katzenschlager R. et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain / Am. J. Cardiol. 2000; 86(2): 207–210. http:// www.ajconline.org/article/S0002-9149(00)00857-2/fulltext.

12. Nitenberg A. Hypertension, endothelial dysfunction and cardiovascular risk / Arch. Mal. Coeur. Vaiss. 2006; 99(10): 915–921.

13. Perticone F., Maio R., Sciacqua A. et al. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension / Diabetes. 2008; 57(1): 167–171. http://diabetes. diabetesjournals.org/content/57/1/167.long.

14. Shechter M., Issachar A., Marai I. et al. Long-term association of brachial artery flowmediated vasodilation and cardiovascular events in middleaged subjects with no apparent heart disease / Int. J. Cardiol. 2009; 134(1): 52–58. http://www.internation aljournalofcardiology.com/article/S0167-5273(08)00311-2/ fulltext.

15. Shimbo D., Muntner P., Mann D. et al. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis / Hypertension. 2010; 55(5): 1210–1216. http://hyper. ahajournals.org/content/55/5/1210.long.

16. Zhang Y., Thompson A.M., Tong W. et al. Biomarkers of inflammation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China / J. Hypertens. 2010; 28(1): 35–40. https://insights.ovid.com/pubmed?pmid=19770776.